On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > REGULATORY
REGULATORY
- Japan Speeds Up Vaccine Delivery for HCPs, Kono Says All 2nd Doses to Reach Municipalities in 1st Half of May
March 8, 2021
- MHLW Presents Views on “Pharma Industry Vision 2021” to LDP’s Project Team
March 8, 2021
- Japan Confirms 1st Case of Anaphylaxis from COVID-19 Vaccination
March 8, 2021
- Japan to Review Moderna Vaccine with Top Priority, May OK Possible: Minister
March 8, 2021
- Pfizer, Bayer to Pull Plug on “G1” Products with High Generic Erosions
March 5, 2021
- MHLW Announces New Drug Prices for 1st Off-Year Revision in April
March 5, 2021
- Vaccine Minister Says Govt to Stick to 3 Week Interval for Now
March 4, 2021
- MHLW Weighs 6-Week Dosing Interval for Pfizer Vaccine
March 4, 2021
- Vaccine Freezer Breakdown Due to Power Shortage: MHLW
March 4, 2021
- Nichi-Iko Ordered to Suspend Biz over Sloppy Manufacturing
March 3, 2021
- All Municipalities to Get 1 Carton of COVID-19 Vaccines for Elderly in Final Week of April: MHLW
March 3, 2021
- Freezers for Moderna Vaccine Could Be Used for Comirnaty Too: Campaign Minister
March 3, 2021
- Woman Dies 3 Days after COVID-19 Vaccine Shot, but Link Indeterminable
March 3, 2021
- MHLW Unveils List of “Stable Supply Medicines”
March 2, 2021
- Nichi-Iko to Get Business Suspension Order on March 3
March 2, 2021
- MHLW Study Group Compiles Guideline for Collecting COVID-19 Convalescent Plasma
March 2, 2021
- 172 Vials of Pfizer Vaccine Unusable due to Freezer Breakdown
March 2, 2021
- MHLW Asks Municipalities to Secure Adrenaline Preparations for Anaphylaxis
March 1, 2021
- PAFSC Minutes for Pfizer Vaccine Disclosed
March 1, 2021
- Govt to Deliver 1st COVID-19 Vaccine Dose for 3.7 Million HCPs in April: Minister
March 1, 2021
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…